News

VIDEO: Dementia rate doubled in type 1 diabetics

Posted on: 21/07/2015 - 17:12

WASHINGTON – Improved management of patients with type 1 diabetes and the resulting increased longevity it has fostered has produced a new medical concern that few patients faced in the past: their...

Field of Interest: Geriatrics
Type: News Item

Moderate THST was most effective at treating thyroid cancer

Posted on: 17/07/2015 - 19:56

Moderate thyroid hormone suppression therapy (THST) is associated with the best outcomes for patients with all stages of thyroid cancer, according to a prospective analysis of a multi-institutional...

Field of Interest: Oncology
Type: News Item

Bills emerge to increase birth control access

Posted on: 16/07/2015 - 21:12

There’s been a flurry of legislative activity on Capitol Hill and at state houses around the country aimed at improving access to contraception. But there are still deep divides on the best way to...

Field of Interest: Pulmonology
Type: News Item

Usual physiotherapy remains best approach in knee OA

Posted on: 15/07/2015 - 17:53

ROME – There was no advantage to individually prescribed exercises for knee osteoarthritis over usual physiotherapy in a multicenter, longitudinal, randomized study reported at the European Congress...

Field of Interest: Geriatrics
Type: News Item

Usual physiotherapy remains best approach in knee OA

Posted on: 15/07/2015 - 17:53

ROME – There was no advantage to individually prescribed exercises for knee osteoarthritis over usual physiotherapy in a multicenter, longitudinal, randomized study reported at the European Congress...

Field of Interest: Rheumatology
Type: News Item

WCD: Pramocaine is a common contact sensitizer

Posted on: 14/07/2015 - 19:38

VANCOUVER – Pramocaine, a topical anesthetic long used in many OTC anti-itch preparations, turns out to itself be a common cause of contact sensitization, Dr. Mariam Abbas reported at the World...

Field of Interest: Dermatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More